Increased CD4+ T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased CD4+ T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients
Authors
Keywords
DNA methylation, CD4-positive T lymphocytes, Urinary bladder neoplasms
Journal
Clinical Epigenetics
Volume 10, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-03
DOI
10.1186/s13148-018-0536-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Epidemiology of Bladder Cancer
- (2015) Núria Malats et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- CpG Methylation of the IFNG Gene as a Mechanism to Induce Immunosupression in Tumor-Infiltrating Lymphocytes
- (2014) P. C. J. Janson et al. JOURNAL OF IMMUNOLOGY
- EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines
- (2013) J. Alfred Witjes et al. EUROPEAN UROLOGY
- Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: Current understanding and perspectives on engineered BCG vaccine
- (2012) Koji Kawai et al. CANCER SCIENCE
- The effects of chemotherapeutic drugs on human monocyte-derived dendritic cell differentiation and antigen presentation
- (2012) J. Hu et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Epidemiology and Risk Factors of Urothelial Bladder Cancer
- (2012) Maximilian Burger et al. EUROPEAN UROLOGY
- FOXP3 and survival in urinary bladder cancer
- (2011) Malin E. Winerdal et al. BJU INTERNATIONAL
- Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder Cancer
- (2011) Robert Rosenblatt et al. EUROPEAN UROLOGY
- The emerging role of CXCL10 in cancer (Review)
- (2011) MINGLI LIU et al. Oncology Letters
- Differentiation of Effector CD4 T Cell Populations
- (2010) Jinfang Zhu et al. Annual Review of Immunology
- Profiling of CD4+ T Cells with Epigenetic Immune Lineage Analysis
- (2010) P. C. J. Janson et al. JOURNAL OF IMMUNOLOGY
- Effector T cell plasticity: flexibility in the face of changing circumstances
- (2010) Kenneth M Murphy et al. NATURE IMMUNOLOGY
- CXCL10 expression and prognostic significance in stage II and III colorectal cancer
- (2009) Zheng Jiang et al. MOLECULAR BIOLOGY REPORTS
- FOXP3 Promoter Demethylation Reveals the Committed Treg Population in Humans
- (2008) Peter C. J. Janson et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started